From: Increased sialylation of site specific O-glycoforms of hemopexin in liver disease
m/z | Delta (ppm) | Glycan composition | XIC (%) |
---|---|---|---|
973.5 (3+) | 9.55 | HexNAc | 0.35 |
770.9 (4+) | 2.08 | HexNAc-Gal | 1.74 |
843.6 (4+) | 3.20 | HexNAc-Gal-Neu5Ac | 66.19 |
916.4 (4+) | 3.38 | HexNAc-Gal-2Neu5Ac | 19.61 |
894.4 (4+) | −0.67 | 2HexNAc-Gal-Neu5Ac | 0.16 |
934.9 (4+) | 3.85 | 2HexNAc-2Gal-Neu5Ac | 0.38 |
1007.7 (4+) | 3.27 | 2HexNAc-2Gal-2Neu5Ac | 7.22 |
1080.5 (4+) | 4.54 | 2HexNAc-2Gal-3Neu5Ac | 1.62 |
1153.2 (4+) | 5.81 | 2HexNAc-2Gal-4Neu5Ac | 0.68 |
1058.5 (4+) | −5.29 | 3HexNAc-2Gal-2Neu5Ac | 0.09 |
1099.0 (4+) | 6.10 | 3HexNAc-3Gal-2Neu5Ac | 0.15 |
937.6 (5+) | 3.73 | 3HexNAc-3Gal-3Neu5Ac | 1.23 |
995.8 (5+) | 0.40 | 3HexNAc-3Gal-4Neu5Ac | 0.45 |
1054.0 (5+) | 1.99 | 3HexNAc-3Gal-5Neu5Ac | 0.08 |
1112.3 (5+) | 11.60 | 3HexNAc-3Gal-6Neu5Ac | 0.04 |